2
RESEARCH METHODOLOGY
34
5
MARKET OVERVIEW
Explore growth avenues in CGM market driven by aging population and tech innovations amidst cost challenges.
54
5.2.1.1
INCREASING PREVALENCE OF DIABETES
5.2.1.2
GROWING ELDERLY POPULATION AND INCREASING LIFE EXPECTANCY
5.2.1.3
RISE IN R&D INVESTMENTS AND LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS
5.2.1.4
WELLNESS & PREVENTIVE USE OF CGMS BEYOND DIABETES
5.2.2.1
HIGH COST AND SOCIOECONOMIC DISPARITIES IN ACCESS TO BLOOD GLUCOSE SENSORS
5.2.2.2
SHORT SENSOR LIFESPAN AND FREQUENT REPLACEMENTS
5.2.3.1
INTEGRATION WITH DIGITAL HEALTH PLATFORMS AND SMART DEVICES
5.2.4.1
REGULATORY AND COMPLIANCE CHALLENGES FOR NON-INVASIVE GLUCOSE MONITORING TECHNOLOGIES
5.2.4.2
DATA OVERLOAD & ALARM FATIGUE
5.2.4.3
FINANCIAL BURDEN AND COVERAGE GAPS
5.3
UNMET NEEDS & WHITE SPACES
5.3.1
UNMET NEEDS IN BLOOD GLUCOSE MONITOR MARKET
5.3.2
WHITE SPACE OPPORTUNITIES
5.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
5.4.1
INTERCONNECTED MARKETS
5.4.2
CROSS-SECTOR OPPORTUNITIES
6
INDUSTRY TRENDS
Navigate industry shifts with strategic insights into diabetes care and insulin delivery trends.
63
6.1
PORTER’S FIVE FORCES ANALYSIS
6.1.1
THREAT OF NEW ENTRANTS
6.1.2
INTENSITY OF COMPETITIVE RIVALRY
6.1.3
BARGAINING POWER OF BUYERS
6.1.4
BARGAINING POWER OF SUPPLIERS
6.1.5
THREAT OF SUBSTITUTES
6.2
MACROECONOMIC OUTLOOK
6.2.2
GDP TRENDS AND FORECAST
6.2.3
TRENDS IN DIABETES CARE INDUSTRY
6.2.4
TRENDS IN GLOBAL INSULIN DELIVERY SYSTEMS INDUSTRY
6.3
SUPPLY CHAIN ANALYSIS
6.6.1
AVERAGE SELLING PRICE OF BLOOD GLUCOSE MONITORS, BY PRODUCT, 2024
6.6.2
AVERAGE SELLING PRICE TREND OF SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2022–2024
6.6.3
PRODUCT PURCHASE CYCLE, BY PRODUCT SEGMENT
6.7.1
IMPORT DATA FOR HS CODE 9027, 2020–2024
6.7.2
EXPORT DATA FOR HS CODE 9027, 2020–2024
6.8
KEY CONFERENCES & EVENTS, 2025–2026
6.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6.10
INVESTMENT & FUNDING SCENARIO
6.11.1
CASE STUDY 1: LONG-TERM GLUCOSE MONITORING FOR SENSITIVE SKIN PATIENTS USING SENSEONICS’ EVERSENSE E3 IMPLANTABLE SENSOR
6.11.2
CASE STUDY 2: ENHANCING PATIENT ADHERENCE AND GLYCEMIC CONTROL USING ABBOTT’S FREESTYLE LIBRE 2 CGM
6.11.3
CASE STUDY 3: IMPROVING GLYCEMIC CONTROL WITH DEXCOM G6 CGM SYSTEM
6.12
IMPACT OF 2025 US TARIFFS ON BLOOD GLUCOSE MONITOR MARKET
6.12.3
PRICE IMPACT ANALYSIS
6.12.5
IMPACT ON END-USE INDUSTRIES
7
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL AND AI ADOPTION
Harnessing AI and patents to revolutionize blood glucose monitoring with innovative tech and strategic foresight.
84
7.1
KEY EMERGING TECHNOLOGIES
7.2
COMPLEMENTARY TECHNOLOGIES
7.2.1
BATTERY AND ENERGY HARVESTING INNOVATIONS
7.3
TECHNOLOGY/PRODUCT ROADMAP
7.3.1
SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
7.3.2
MID TERM (2027–2030) | EXPANSION & STANDARDIZATION
7.3.3
LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
7.4.1
PATENT PUBLICATION TRENDS FOR BLOOD GLUCOSE MONITOR MARKET
7.4.2
TOP APPLICANTS (COMPANIES) OF BLOOD GLUCOSE MONITOR PATENTS
7.4.3
JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN BLOOD GLUCOSE MONITOR MARKET
7.4.4
LIST OF MAJOR PATENTS
7.6
IMPACT OF AI/GEN AI ON BLOOD GLUCOSE MONITOR MARKET
7.6.1
TOP USE CASES AND MARKET POTENTIAL
7.6.2
TOP CASE STUDIES OF AI IMPLEMENTATION IN BLOOD GLUCOSE MONITOR MARKET
7.6.3
INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
7.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN BLOOD GLUCOSE MONITOR MARKET
7.7
SUCCESS STORIES & REAL-WORLD APPLICATIONS
7.7.1
ABBOTT: FREESTYLE LIBRE 3—MINIATURIZED SENSOR WITH REAL-TIME CONNECTIVITY
7.7.2
DEXCOM: G7 SENSOR—ADVANCED ALGORITHM FOR ACCURATE AND FAST GLUCOSE READINGS
7.7.3
SENSEONICS: EVERSENSE E3—LONG-TERM IMPLANTABLE CGM WITH SMART ALERTS
8
TREATMENT & REGULATORY LANDSCAPE
Navigate global diabetes treatment regulations with insights into regional compliance and eco-standards.
93
8.1
REGIONAL REGULATIONS & COMPLIANCE
8.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.2
REGULATORY STANDARDS
8.2
EPIDEMIOLOGY OF DIABETES, BY KEY COUNTRY
8.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8.3.1
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN BLOOD GLUCOSE MONITOR MARKET
8.4
TREATMENT AND REGULATORY LANDSCAPE
8.4.1
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
9
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock market profitability by understanding key stakeholders and overcoming adoption barriers.
100
9.1
DECISION-MAKING PROCESS
9.2
KEY STAKEHOLDERS & BUYING CRITERIA
9.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
9.2.2
KEY BUYING CRITERIA
9.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
9.4
UNMET NEEDS OF END USERS
9.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
10
BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 19 Data Tables
105
10.2
SELF-MONITORING BLOOD GLUCOSE SYSTEMS
10.2.1.1
REGULATORY REINFORCEMENT AND DIGITAL INTEGRATION TO DRIVE ADVANCEMENTS IN MARKET
10.2.2.1
SHIFT TOWARD NON-INVASIVE METHODS FOR BLOOD GLUCOSE MONITORING TO RESTRAIN MARKET GROWTH
10.2.3
LANCETS & LANCING DEVICES
10.2.3.1
RISING FOCUS ON REDUCING CHANCES OF INFECTION TO INCREASE POPULARITY OF SAFETY LANCETS
10.3
CONTINUOUS GLUCOSE MONITORING SYSTEMS
10.3.1.1
TECHNOLOGICAL ADVANCEMENTS AND EXPANDING USE IN DIABETES MANAGEMENT TO BOOST MARKET GROWTH
10.3.2.1
RISING DEMAND FOR LONG-DURATION SENSORS OFFERING EXTENDED LIFESPAN AND REDUCED REPLACEMENT FREQUENCY TO DRIVE GROWTH
10.3.3
TRANSMITTERS & RECEIVERS
10.3.3.1
INTEGRATION WITH SMART MONITORING SYSTEMS AND INTEROPERABLE DIABETES MANAGEMENT PLATFORMS TO FUEL GROWTH
10.4
PROFESSIONAL POINT-OF-CARE DEVICES
10.4.1
ADVANCING PATIENT CARE THROUGH DECENTRALIZED POINT-OF-CARE GLUCOSE MONITORING TO BOOST MARKET
10.5
NON-INVASIVE PRODUCTS
10.5.1
RISING PATIENT PREFERENCE FOR PAINLESS TECHNOLOGY TO FOSTER DEVELOPMENT AND ADOPTION IN FUTURE
11
BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
123
11.2.1
HIGH ACCURACY ASSOCIATED WITH FINGERTIP TESTING TO SUPPORT MARKET GROWTH
11.3.1
RISE OF CONTINUOUS AND MINIMALLY INVASIVE MONITORING TECHNOLOGIES TO BOOST DEMAND FOR UPPER ARM TESTING
12
BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 7 Data Tables
129
12.2.1.1
INTENSIVE MANAGEMENT NEEDS ASSOCIATED WITH TYPE 1 DIABETES TO BOOST ADOPTION
12.2.2.1
HIGH PREVALENCE OF TYPE 2 DIABETES TO DRIVE MARKET DEMAND
12.3
HEALTH & WELLNESS MONITORING
12.3.1
EMERGING ROLE OF HEALTH & WELLNESS MONITORING FOR BLOOD GLUCOSE MONITORS TO DRIVE MARKET GROWTH
13
BLOOD GLUCOSE MONITOR MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
138
13.2.1
CONVENIENT, COST-EFFECTIVE, AND FREQUENT MONITORING ASSOCIATED WITH HOME CARE SETTINGS TO DRIVE MARKET
13.3.1
STRATEGIC ADOPTION OF BLOOD GLUCOSE SENSORS IN HOSPITALS & CLINICS TO DRIVE MARKET VALIDATION AND GROWTH
14
BLOOD GLUCOSE MONITOR MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 166 Data Tables.
144
14.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2.1
US TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN BLOOD GLUCOSE MONITOR MARKET
14.2.3.1
RISING GOVERNMENT SUPPORT TO BOOST BLOOD GLUCOSE MONITOR MARKET IN CANADA
14.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2.1
GERMANY TO DOMINATE EUROPEAN BLOOD GLUCOSE MONITOR MARKET
14.3.3.1
GOVERNMENT SUPPORT AND RESEARCH FUNDING TO DRIVE BLOOD GLUCOSE MONITOR MARKET GROWTH IN UK
14.3.4.1
HIGH INSURANCE COVERAGE AND INCREASING AFFORDABILITY TO SUPPORT MARKET GROWTH
14.3.5.1
INCREASING GOVERNMENT SPENDING TO DRIVE MARKET GROWTH IN ITALY
14.3.6.1
HIGH DIABETES PREVALENCE TO DRIVE MARKET GROWTH IN SPAIN
14.3.7
REST OF EUROPE (ROE)
14.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2.1
CHINA TO DOMINATE ASIA PACIFIC BLOOD GLUCOSE MONITOR MARKET
14.4.3.1
RISING AGING POPULATION AND HIGH NUMBER OF DIABETES CASES TO DRIVE MARKET GROWTH IN JAPAN
14.4.4.1
RISING DIABETES CASES AND AFFORDABLE LOCAL MANUFACTURING TO FUEL INSULIN DEVICE DEMAND IN INDIA
14.4.5.1
GOVERNMENT SUBSIDIES TO DRIVE MARKET
14.4.6.1
RISING DIABETES CASES ACROSS COUNTRY TO BOOST MARKET
14.4.7
REST OF ASIA PACIFIC
14.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2.1
BRAZIL TO ACCOUNT FOR LARGEST SHARE OF LATIN AMERICAN BLOOD GLUCOSE MONITOR MARKET
14.5.3.1
RISING DIABETES PREVALENCE TO DRIVE MARKET GROWTH
14.5.4
REST OF LATIN AMERICA
14.6
MIDDLE EAST & AFRICA
14.6.1
INTERNATIONAL AID PROGRAMS AND GOVERNMENT-LED INITIATIVES FOR NON-COMMUNICABLE DISEASE MANAGEMENT TO FOSTER GROWTH
14.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
14.7.1
RISING DIABETES PREVALENCE TO DRIVE MARKET IN GCC COUNTRIES
14.7.2
MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
15
COMPETITIVE LANDSCAPE
Uncover strategic dominance and growth trajectories in the blood glucose monitor market.
217
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
15.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BLOOD GLUCOSE MONITOR MARKET
15.3
REVENUE ANALYSIS, 2020–2024
15.4
MARKET SHARE ANALYSIS, 2024
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
REGION FOOTPRINT
15.5.5.3
PRODUCT TYPE FOOTPRINT
15.5.5.4
TEST SITE FOOTPRINT
15.5.5.5
APPLICATION FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
15.7
COMPANY VALUATION & FINANCIAL METRICS
15.8
BRAND/PRODUCT COMPARISON
15.9
R&D EXPENDITURE OF KEY PLAYERS
15.10
COMPETITIVE SCENARIO
15.10.1
PRODUCT LAUNCHES & APPROVALS
15.10.4
OTHER DEVELOPMENTS
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
238
16.1.1
ABBOTT LABORATORIES
16.1.1.1
BUSINESS OVERVIEW
16.1.1.2
PRODUCTS OFFERED
16.1.1.3
RECENT DEVELOPMENTS
16.1.5
ROCHE DIABETES CARE
16.1.9
ASCENSIA DIABETES CARE HOLDINGS AG
16.1.11
NEMAURA MEDICAL INC.
16.1.12
MEDICAL TECHNOLOGY AND DEVICES S.P.A.
16.1.13
TERUMO CORPORATION
16.1.14
LIFESCAN IP HOLDINGS, LLC
16.2.1
ACON LABORATORIES, INC.
16.2.3
PRODIGY DIABETES CARE, LLC
16.2.4
ULTRAHUMAN HEALTHCARE PVT. LTD.
16.2.7
SD BIOSENSOR, INC.
16.2.8
A. MENARINI DIAGNOSTICS S.R.L
16.2.11
ROSSMAX INTERNATIONAL LTD.
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
TABLE 1
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 2
RISK ASSESSMENT: BLOOD GLUCOSE MONITOR MARKET
TABLE 3
BLOOD GLUCOSE MONITOR MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 5
BLOOD GLUCOSE MONITOR MARKET: ROLE IN ECOSYSTEM
TABLE 6
AVERAGE SELLING PRICE OF BLOOD GLUCOSE MONITORS, BY PRODUCT, 2024
TABLE 7
AVERAGE SELLING PRICE TREND OF SELF-MONITORING BLOOD GLUCOSE SYSTEMS, BY REGION, 2022–2024
TABLE 8
IMPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 9
EXPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 10
BLOOD GLUCOSE MONITOR MARKET: LIST OF KEY CONFERENCES & EVENTS, 2025–2026
TABLE 11
CASE STUDY 1: LONG-TERM GLUCOSE MONITORING FOR SENSITIVE SKIN PATIENTS USING SENSEONICS’ EVERSENSE E3 IMPLANTABLE SENSOR
TABLE 12
CASE STUDY 2: ENHANCING PATIENT ADHERENCE AND GLYCEMIC CONTROL USING ABBOTT’S FREESTYLE LIBRE 2 CGM
TABLE 13
CASE STUDY 3: MPROVING GLYCEMIC CONTROL WITH DEXCOM G6 CGM SYSTEM
TABLE 14
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 15
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR BLOOD GLUCOSE MONITOR PRODUCTS
TABLE 16
BLOOD GLUCOSE MONITOR MARKET: LIST OF MAJOR PATENTS
TABLE 17
UPCOMING AND PIPELINE PRODUCTS IN GLOBAL BLOOD GLUCOSE MONITOR MARKET
TABLE 18
TOP USE CASES AND MARKET POTENTIAL
TABLE 19
BLOOD GLUCOSE MONITOR MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 20
INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
TABLE 21
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26
DIABETES PREVALENCE, BY KEY COUNTRY
TABLE 27
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
TABLE 28
KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 29
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 30
BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 31
COMPANIES OFFERING SELF-MONITORING BLOOD GLUCOSE (SMBG) SYSTEMS
TABLE 32
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 33
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET FOR GLUCOMETERS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 35
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET FOR GLUCOMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET FOR TESTING STRIPS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET FOR LANCETS & LANCING DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
COMPANIES OFFERING CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS
TABLE 39
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 40
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 42
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR IMPLANTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS & RECEIVERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
COMPANIES OFFERING PROFESSIONAL POINT-OF-CARE DEVICES
TABLE 46
PROFESSIONAL POINT-OF-CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
COMPANIES OFFERING NON-INVASIVE PRODUCTS
TABLE 48
NON-INVASIVE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 50
BLOOD GLUCOSE MONITOR MARKET FOR FINGERTIP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
BLOOD GLUCOSE MONITOR MARKET FOR UPPER ARM TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
BLOOD GLUCOSE MONITOR MARKET FOR OTHER TEST SITES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 54
BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 55
BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
BLOOD GLUCOSE MONITOR MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
BLOOD GLUCOSE MONITOR MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
BLOOD GLUCOSE MONITOR MARKET FOR HEALTH & WELLNESS MONITORING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
BLOOD GLUCOSE MONITOR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 61
BLOOD GLUCOSE MONITOR MARKET FOR SELF/HOME CARE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
BLOOD GLUCOSE MONITOR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
BLOOD GLUCOSE MONITOR MARKET FOR OTHER END USER, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
BLOOD GLUCOSE MONITOR MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 67
NORTH AMERICA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 69
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 71
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 72
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 73
US: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 74
US: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
US: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 77
US: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 78
US: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 79
US: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 80
CANADA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 81
CANADA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83
CANADA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 84
CANADA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 85
CANADA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 86
CANADA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 87
EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 88
EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 89
EUROPE: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91
EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 92
EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 93
EUROPE: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 94
EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 95
GERMANY: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 96
GERMANY: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
GERMANY: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 99
GERMANY: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 100
GERMANY: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 101
GERMANY: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 102
UK: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 103
UK: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
UK: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 106
UK: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 107
UK: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
UK: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109
FRANCE: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 110
FRANCE: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
FRANCE: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 113
FRANCE: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 114
FRANCE: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 115
FRANCE: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 116
ITALY: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 117
ITALY: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
ITALY: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 120
ITALY: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 121
ITALY: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
ITALY: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 123
SPAIN: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 124
SPAIN: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
SPAIN: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 127
SPAIN: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 128
SPAIN: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
SPAIN: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 130
REST OF EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 131
REST OF EUROPE: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
REST OF EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 134
REST OF EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 135
REST OF EUROPE: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
REST OF EUROPE: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 137
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 139
ASIA PACIFIC: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
ASIA PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 142
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 143
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 145
CHINA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 146
CHINA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
CHINA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 149
CHINA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 150
CHINA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
CHINA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 152
JAPAN: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 153
JAPAN: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
JAPAN: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 156
JAPAN: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 157
JAPAN: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
JAPAN: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 159
INDIA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 160
INDIA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
INDIA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 163
INDIA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 164
INDIA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
INDIA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 166
AUSTRALIA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 167
AUSTRALIA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
AUSTRALIA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 170
AUSTRALIA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 171
AUSTRALIA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 172
AUSTRALIA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 173
SOUTH KOREA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 174
SOUTH KOREA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
SOUTH KOREA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 177
SOUTH KOREA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 178
SOUTH KOREA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
SOUTH KOREA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 180
REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 181
REST OF ASIA PACIFIC: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
REST OF ASIA PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 187
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 189
LATIN AMERICA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 192
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 193
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 195
BRAZIL: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 196
BRAZIL: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
BRAZIL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
BRAZIL: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 199
BRAZIL: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 200
BRAZIL: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
BRAZIL: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 202
MEXICO: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 203
MEXICO: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
MEXICO: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
MEXICO: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 206
MEXICO: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 207
MEXICO: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
MEXICO: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 209
REST OF LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 210
REST OF LATIN AMERICA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
REST OF LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
REST OF LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 213
REST OF LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 214
REST OF LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
REST OF LATIN AMERICA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 216
MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 217
MIDDLE EAST & AFRICA: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 221
MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 223
GCC COUNTRIES: BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 224
GCC COUNTRIES: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
GCC COUNTRIES: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
GCC COUNTRIES: BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2023–2030 (USD MILLION)
TABLE 227
GCC COUNTRIES: BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 228
GCC COUNTRIES: BLOOD GLUCOSE MONITOR MARKET FOR DIABETES MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
GCC COUNTRIES: BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 230
STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD GLUCOSE MONITOR MARKET, JANUARY 2022–SEPTEMBER 2025
TABLE 231
BLOOD GLUCOSE MONITOR MARKET: DEGREE OF COMPETITION
TABLE 232
BLOOD GLUCOSE MONITOR MARKET: REGION FOOTPRINT
TABLE 233
BLOOD GLUCOSE MONITOR MARKET: PRODUCT TYPE FOOTPRINT
TABLE 234
BLOOD GLUCOSE MONITOR MARKET: TEST SITE FOOTPRINT
TABLE 235
BLOOD GLUCOSE MONITOR MARKET: APPLICATION FOOTPRINT
TABLE 236
BLOOD GLUCOSE MONITOR MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 237
BLOOD GLUCOSE MONITOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (1/2)
TABLE 238
BLOOD GLUCOSE MONITOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES (2/2)
TABLE 239
BLOOD GLUCOSE MONITOR MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 240
BLOOD GLUCOSE MONITOR MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 241
BLOOD GLUCOSE MONITOR MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 242
BLOOD GLUCOSE MONITOR MARKET: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 243
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 244
ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 245
ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 246
ABBOTT LABORATORIES: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 247
ABBOTT LABORATORIES: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 248
ABBOTT LABORATORIES: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 249
DEXCOM, INC.: COMPANY OVERVIEW
TABLE 250
DEXCOM, INC.: PRODUCTS OFFERED
TABLE 251
DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 252
DEXCOM, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 253
MEDTRONIC: COMPANY OVERVIEW
TABLE 254
MEDTRONIC: PRODUCTS OFFERED
TABLE 255
MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 256
MEDTRONIC: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 257
MEDTRONIC: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 258
MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 259
SINOCARE: COMPANY OVERVIEW
TABLE 260
SINOCARE: PRODUCTS OFFERED
TABLE 261
SINOCARE: PRODUCT APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 262
SINOCARE: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 263
SINOCARE: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 264
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 265
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 266
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 267
F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 268
B. BRAUN SE: COMPANY OVERVIEW
TABLE 269
B. BRAUN SE: PRODUCTS OFFERED
TABLE 270
I-SENS, INC.: COMPANY OVERVIEW
TABLE 271
I-SENS, INC.: PRODUCTS OFFERED
TABLE 272
I-SENS, INC.: PRODUCT APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 273
I-SENS, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 274
SENSEONICS: COMPANY OVERVIEW
TABLE 275
SENSEONICS: PRODUCTS OFFERED
TABLE 276
SENSEONICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 277
SENSEONICS: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 278
SENSEONICS: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 279
ASCENSIA DIABETES CARE HOLDINGS AG: COMPANY OVERVIEW
TABLE 280
ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCTS OFFERED
TABLE 281
ASCENSIA DIABETES CARE HOLDINGS AG: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025
TABLE 282
ASCENSIA DIABETES CARE HOLDINGS AG: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 283
NIPRO: COMPANY OVERVIEW
TABLE 284
NIPRO: PRODUCTS OFFERED
TABLE 285
NIPRO: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 286
NEMAURA MEDICAL INC.: COMPANY OVERVIEW
TABLE 287
NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 288
NEMAURA MEDICAL INC.: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 289
MEDICAL TECHNOLOGY AND DEVICES S.P.A.: COMPANY OVERVIEW
TABLE 290
MEDICAL TECHNOLOGY AND DEVICES S.P.A.: PRODUCTS OFFERED
TABLE 291
MEDICAL TECHNOLOGY AND DEVICES S.P.A.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 292
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 293
TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 294
TERUMO CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 295
TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 296
TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025
TABLE 297
LIFESCAN IP HOLDINGS, LLC: COMPANY OVERVIEW
TABLE 298
LIFESCAN IP HOLDINGS, LLC: PRODUCTS OFFERED
TABLE 299
LIFESCAN IP HOLDINGS, LLC: DEALS, JANUARY 2022–SEPTEMBER 2025
FIGURE 1
BLOOD GLUCOSE MONITOR MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
YEARS CONSIDERED
FIGURE 3
BLOOD GLUCOSE MONITOR MARKET: RESEARCH DESIGN
FIGURE 4
BLOOD GLUCOSE MONITOR MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
BLOOD GLUCOSE MONITOR MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE)
FIGURE 6
BLOOD GLUCOSE MONITOR MARKET: KEY INDUSTRY INSIGHTS
FIGURE 7
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9
BLOOD GLUCOSE MONITOR MARKET SIZE ESTIMATION
FIGURE 10
REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
FIGURE 11
BLOOD GLUCOSE MONITOR MARKET: REVENUE ANALYSIS OF TOP 5 COMPANIES (2024)
FIGURE 12
BLOOD GLUCOSE MONITOR MARKET: EPIDEMIC MODEL ANALYSIS
FIGURE 13
BLOOD GLUCOSE MONITOR MARKET: TOP-DOWN APPROACH
FIGURE 14
BLOOD GLUCOSE MONITORMARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024)
FIGURE 15
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF BLOOD GLUCOSE MONITOR MARKET (2025–2030)
FIGURE 16
BLOOD GLUCOSE MONITOR MARKET: DATA TRIANGULATION
FIGURE 17
BLOOD GLUCOSE MONITOR MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 18
BLOOD GLUCOSE MONITOR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19
BLOOD GLUCOSE MONITOR MARKET, BY TEST SITE, 2025 VS. 2030 (USD MILLION)
FIGURE 20
BLOOD GLUCOSE MONITOR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 21
GEOGRAPHICAL SNAPSHOT OF BLOOD GLUCOSE MONITOR MARKET
FIGURE 22
INCREASING TECHNOLOGICAL ADVANCEMENTS IN BLOOD GLUCOSE MONITOR MARKET TO DRIVE GROWTH
FIGURE 23
CHINA ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024
FIGURE 24
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 25
ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2025–2030)
FIGURE 26
DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 27
BLOOD GLUCOSE MONITOR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28
HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP FOR 1995, 2005, 2014, AND 2024
FIGURE 29
BLOOD GLUCOSE MONITOR MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30
BLOOD GLUCOSE MONITOR MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 31
BLOOD GLUCOSE MONITOR MARKET: VALUE CHAIN ANALYSIS
FIGURE 32
BLOOD GLUCOSE MONITOR MARKET: ECOSYSTEM ANALYSIS
FIGURE 33
BLOOD GLUCOSE MONITOR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 34
BLOOD GLUCOSE MONITOR MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
FIGURE 35
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BLOOD GLUCOSE MONITORS (JANUARY 2015–APRIL 2025)
FIGURE 36
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BLOOD GLUCOSE MONITOR PATENTS, 2015–2025
FIGURE 37
KEY FEATURES OF AI/GENERATIVE AI IN BLOOD GLUCOSE MONITOR MARKET
FIGURE 38
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
FIGURE 39
KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
FIGURE 40
BLOOD GLUCOSE MONITOR MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 41
NORTH AMERICA: BLOOD GLUCOSE MONITOR MARKET SNAPSHOT
FIGURE 42
ASIA PACIFIC: BLOOD GLUCOSE MONITOR MARKET SNAPSHOT
FIGURE 43
REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD GLUCOSE MONITOR MARKET, 2020–2024
FIGURE 44
MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD GLUCOSE MONITOR MARKET (2024)
FIGURE 45
BLOOD GLUCOSE MONITOR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 46
BLOOD GLUCOSE MONITOR MARKET: COMPANY FOOTPRINT
FIGURE 47
BLOOD GLUCOSE MONITOR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 48
EV/EBITDA OF KEY VENDORS
FIGURE 49
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 50
BLOOD GLUCOSE MONITOR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 51
R&D EXPENDITURE OF KEY PLAYERS IN BLOOD GLUCOSE MONITOR MARKET, 2022–2024
FIGURE 52
ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
FIGURE 53
DEXCOM, INC.: COMPANY SNAPSHOT (2024)
FIGURE 54
MEDTRONIC: COMPANY SNAPSHOT (2024)
FIGURE 55
SINOCARE: COMPANY SNAPSHOT (2024)
FIGURE 56
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
FIGURE 57
B. BRAUN SE: COMPANY SNAPSHOT (2024)
FIGURE 58
I-SENS, INC: COMPANY SNAPSHOT (2024)
FIGURE 59
SENSEONICS: COMPANY SNAPSHOT (2024)
FIGURE 60
NIPRO: COMPANY SNAPSHOT (2024)
FIGURE 61
TERUMO CORPORATION: COMPANY SNAPSHOT (2024)
Growth opportunities and latent adjacency in Blood Glucose Monitor Market